[tdc_zone][vc_row][vc_column width=”1/2″][td_block_text_with_title custom_title=”Melinta Therapeutics (NASDAQ: MLNT)”]
Official Melinta Therapeutics logo.
Melinta Therapeutics Inc (NASDAQ: MLNT) is a biotechnology copany taking a novel approach to the treatment of various infections.
The company is in commercial stages, and in mid 2019, it announced that the FDA accepted a supplemental New Drug Application for BAXDELA, a treatment approved for skin infections. If approved, the label on BAXDELA will be expanded to include the treatment of community acquired bacteral pneumonia, entering a large
Visit the Melinta Therapeutics investor relations website here.
[/td_block_text_with_title][td_block_18 custom_title=”Melinta Therapeutics (NASDAQ: MLNT) Reports From Alpha Stock News” limit=”3″ tag_slug=”MLNT”][/vc_column][vc_column width=”1/2″ vertical_align=”top”][vc_widget_sidebar sidebar_id=”td-mlnt”][/vc_column][/vc_row][vc_row row_divider_top=””][vc_column width=”1/1″][vc_widget_sidebar sidebar_id=”td-mlnt-bottom”][vc_widget_sidebar][/vc_column][/vc_row][/tdc_zone]